Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Most hospitals are not complying with price transparency laws

Hospitals have been required to post their prices of their 300 most common procedures since Jan. 1, 2021. However, a majority of providers are still not fully complying. 

When Apple previewed its watchOS 9 update in early June, one of the key features the company highlighted was a new tracking option for atrial fibrillation (AFib) patients. The AFib History feature, approved for patients 22 years and older who have been diagnosed with AFib, was designed to help users gain a better understanding of their symptoms and easily share data with healthcare providers.

Regulatory Roundup: FDA clears several new solutions, including Apple’s latest AFib offering

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions. 

Radiology contributes less than thought to the national healthcare spend

An analysis of CMS data has shown radiology had little to do with increases in Medicare costs over a 10-year period ending in 2019.

Thumbnail

Cardiologists push back on FDA’s thyroid monitoring/contrast media proposal

According to a new SCAI statement, the FDA's recommendation would result in "far-reaching consequences" across multiple specialties. 

Thumbnail

Breaking: Supreme Court overturns Roe v. Wade

The U.S. Supreme Court has decided to overturn Roe v. Wade, which guaranteed the Constitutional right to abortion access for nearly 50 years.

Contrast shortage update: House Members urge President Biden to intervene

Members who signed the letter were particularly critical of the fact that the shortage is a result of COVID lockdowns in China, stating that this crisis brings to light “the urgent need to establish an outbound investment review process to ensure that critical capabilities are not being offshored ..."

Thumbnail

FDA rules Juul vape products can’t be marketed, sold

The move means Juul Labs cannot sell and distribute its products. Plus, Juul must remove products that are currently on the U.S. market or risk enforcement action.

 

FDA announces another recall for troubled heart device after a patient death

This latest recall involves the device's batteries, which are separating due to a "welding defect."